| Theme | Diagnostic and Therapeutic Guidelines in End-stage Renal Failure | |
|---|---|---|
| Title | Guidelines for managing glycemia and hyperlipidemia in hemodialysis patients | |
| Publish Date | 2004/01 | |
| Author | Arao Futenma | Division of Nephrology and Rheumatology, Aichi Medical University School of Medicine |
| Author | Hirokazu Imai | Division of Nephrology and Rheumatology, Aichi Medical University School of Medicine |
| [ Summary ] | Maintenance of good glycemic control in diabetic patients receiving hemodialysis is important in preveting the development of diabetic angiopathy and other complications. Reliable indices of glycemic states in diabetic dialysis patients were blood glucose (BS), HbA1c and glycated albumin (GA) levels. The practical guidelines for managing good glycemic states were as follows; fasting BS < 120mg/dl, post pradial (2 hrs) BS < 180mg/dl, HbA1c < 7.0% and GA < 20%. In patients with hypoglycemia or with rapidly fluctuating glucose levels there is a need for more flexable control, but HbA1c levels should be maintained below 8.0%. Maniging of hyperlipidemia in dialysis patients is important in preventing the progression of arteriosclerosis. Expected control levels of serum lipids were as follows; LDL-C < 100mg/dl, TG < 150mg/dl, non HDL-C < 130mg/dl and HDL-C => 40mg/dl. |
|